Literature DB >> 7766289

Cerebrospinal fluid biogenic amines in obsessive compulsive disorder, Tourette's syndrome, and healthy controls.

J F Leckman1, W K Goodman, G M Anderson, M A Riddle, P B Chappell, M T McSwiggan-Hardin, C J McDougle, L D Scahill, S I Ort, D L Pauls.   

Abstract

To examine the role of noradrenergic, dopaminergic, and serotonergic mechanisms in the pathobiology of obsessive compulsive disorder (OCD) and Tourette's syndrome (TS), concentrations of tyrosine (TYR), norepinephrine (NE), 3-methoxy-4-hydroxyphenylethylene glycol (MHPG), homovanillic acid (HVA), tryptophan (TRP), and 5-hydroxyindoleacetic acid (5-HIAA) were measured in the lumbar cerebrospinal fluid (CSF) of 39 medication-free OCD patients, 33 medication-free TS patients, and 44 healthy volunteers. CSF TYR concentrations were reduced (p < .05) in the OCD patients compared to the healthy subjects. CSF NE in TS patients was 55% higher than in healthy controls (p < .001) and 35% higher than in OCD patients (p < .001). After covarying for height, CSF HVA levels were reduced (p < .05) in the OCD group compared to TS patients but not compared to the normal volunteers. No mean differences in CSF MHPG, TRP, and 5-HIAA were observed in this study across the three groups. The CSF NE data support the hypothesis that noradrenergic mechanisms are involved in the pathobiology of TS. Alterations in the balance of noradrenergic, dopaminergic, and serotonergic systems are likely involved in the pathobiology of OCD.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7766289     DOI: 10.1038/sj.npp.1380241

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  29 in total

Review 1.  The genetics of Tourette disorder.

Authors:  Matthew W State
Journal:  Curr Opin Genet Dev       Date:  2011-01-27       Impact factor: 5.578

Review 2.  Neurobiological substrates of Tourette's disorder.

Authors:  James F Leckman; Michael H Bloch; Megan E Smith; Daouia Larabi; Michelle Hampson
Journal:  J Child Adolesc Psychopharmacol       Date:  2010-08       Impact factor: 2.576

Review 3.  Tourette syndrome: gene expression as a tool to discover drug targets.

Authors:  Isaac H Liao; Frank R Sharp
Journal:  Neurotherapeutics       Date:  2010-07       Impact factor: 7.620

4.  Abnormal topography of EEG microstates in Gilles de la Tourette syndrome.

Authors:  A Stevens; W Günther; W Lutzenberger; M Bartels; N Müller
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1996       Impact factor: 5.270

5.  Obsessive-compulsive spectrum disorders.

Authors:  A V Ravindran
Journal:  J Psychiatry Neurosci       Date:  1999-01       Impact factor: 6.186

6.  Discrete forebrain neuronal networks supporting noradrenergic regulation of sensorimotor gating.

Authors:  Karen M Alsene; Abha K Rajbhandari; Marcia J Ramaker; Vaishali P Bakshi
Journal:  Neuropsychopharmacology       Date:  2011-01-19       Impact factor: 7.853

Review 7.  Obsessive-compulsive and tic-related disorders.

Authors:  Martin E Franklin; Julie P Harrison; Kristin L Benavides
Journal:  Child Adolesc Psychiatr Clin N Am       Date:  2012-06-16

8.  Adenylate-cyclase activity in platelets of patients with obsessive-compulsive disorder.

Authors:  D Marazziti; S Baroni; L Palego; I Masala; G Consoli; M Catena Dell'osso; G Giannaccini; A Lucacchini
Journal:  Neuropsychiatr Dis Treat       Date:  2009-07-02       Impact factor: 2.570

9.  Correlates of comorbid anxiety and externalizing disorders in childhood obsessive compulsive disorder.

Authors:  Audra K Langley; Adam B Lewin; R Lindsey Bergman; Joyce C Lee; John Piacentini
Journal:  Eur Child Adolesc Psychiatry       Date:  2010-03-28       Impact factor: 4.785

Review 10.  Genetic susceptibility and neurotransmitters in Tourette syndrome.

Authors:  Peristera Paschou; Thomas V Fernandez; Frank Sharp; Gary A Heiman; Pieter J Hoekstra
Journal:  Int Rev Neurobiol       Date:  2013       Impact factor: 3.230

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.